Cognitive Dysfunction as an Initial Manifestation of Rheumatoid Arthritis-associated Intravascular Large B-cell Lymphoma: A Case Report-Reference-Cited by-同舟云学术

Cognitive Dysfunction as an Initial Manifestation of Rheumatoid Arthritis-associated Intravascular Large B-cell Lymphoma: A Case Report

Published:2024 Issue: Volume: Page:
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Kitai Junya¹²,Minoda Sada Ryuichi¹³⁴,Yamaguchi Satoko⁵,Shinde Akiyo⁵,Maruyama Wataru⁶

Affiliation:

1. Department of General Internal Medicine, Tenri Hospital, Japan

2. Department of Inflammation and Immunology, Graduate School of Medical Science, Kyoto Prefectural University of Medicine, Japan

3. Department of Transformative Protection to Infectious Disease, Graduate School of Medicine, Osaka University, Japan

4. Department of Infection Control, Graduate School of Medicine, Osaka University, Japan

5. Department of Neurology, Tenri Hospital, Japan

6. Department of Hematology, Tenri Hospital, Japan

Publisher

Japanese Society of Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/advpub/0/advpub_3817-24/_pdf

Reference36 articles.

1. 1. Shimizu Y, Nakajima A, Inoue E, et al. Characteristics and risk factors of lymphoproliferative disorders among patients with rheumatoid arthritis concurrently treated with methotrexate: a nested case-control study of the IORRA cohort. Clin Rheumatol 36: 1237-1245, 2017.

2. 2. Honda S, Sakai R, Inoue E, et al. Association of methotrexate use and lymphoproliferative disorder in patients with rheumatoid arthritis: Results from a Japanese multi-institutional retrospective study. Mod Rheumatol 32: 16-23, 2022.

3. 3. Banko A, Miljanovic D, Lazarevic I, et al. New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis. Viruses 14: 115, 2022.

4. 4. Gaulard P, Swerdlow SH, Harris NL, Sundstrom C, Jaffe ES. Other Iatrogenic Immunodeficiency-Associated Lymphoproliferative Disorders. In: WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Revised 4th ed. Swerdlow SH, Campo E, Harris NL, et al., Eds. IARC Press, Lyon, 2017: 462-464.

5. 5. Tokuhira M, Tamaru JI, Kizaki M. Clinical management for other iatrogenic immunodeficiency-associated lymphoproliferative disorders. J Clin Exp Hematop 59: 72-92, 2019.